Randamized phase II trial of S-1+CDDP vs S-1+Docetaxel for advanced and/or recurrent gastric cancer
Phase 2
- Conditions
- advanced and/or recurrent gastric cancer
- Registration Number
- JPRN-UMIN000004780
- Lead Sponsor
- Department of Digestive Surgery, Kawasaki Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.With active other cancer(excluded early colonic cancer) 2.With active bleeding 3.With ascites needed to exclude 4.metastasis to the brain 5.With peripheral neuropathy more than Grade 2 6.Interstitial pneumonia 7.With erethism history for 5-FU, TXT, polisorbate 80 8.Previouslly treated by chemoradiation 9.pregnancy and the person of intention to become pregnant 10. participated in other trial wiyhin 4 weeks 11.forbidden to use steroid
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to progression
- Secondary Outcome Measures
Name Time Method Median survival time Response rate The rate of adverse event Median rate of continuing therapy